Boothbay Fund Management »

Cue Biopharma shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $439k 611k 0.72
2022-06-30 $31k 12k 2.51

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Group
Geode Capital Management
Boothbay Fund Management
Robertson Stephens Wealth Management
BlackRock
Advisory Research
Renaissance Technologies
UBS Group
Stifel Financial
State Street Corporation
Susquehanna International
Angeles Wealth Management
Northern Trust

View all funds holding Cue Biopharma